New Two-Pronged attack tested for tough HPV cancers
NCT ID NCT03260023
Summary
This study is testing a new combination of two drugs, TG4001 and avelumab, for people with advanced HPV-16 positive cancers that have returned or spread. The goal is to see if using these drugs together is safe and more effective at controlling the cancer than using avelumab alone. It is for adults with certain HPV-linked cancers, like cervical or anal cancer, that are no longer responding to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Besançon
Besançon, France
-
CLCC Georges-François Leclerc
Dijon, France
-
Centre Léon Bérard
Lyon, France
-
Centre Paul Strauss - ICANS - Institut de cancérologie Strasbourg Europe
Strasbourg, France
-
Fundación de Investigación Biomédica Hospital Clínico San Carlos
Madrid, Spain
-
Fundación de Investigación biomédica H. 12 de Octubre
Madrid, Spain
-
Hopital de la Timone
Marseille, France
-
Hospital General de Valencia
Valencia, Spain
-
Hospital Virgen de La Victoria
Málaga, Spain
-
Hospital Virgen de las Nieves
Granada, Spain
-
Hôpital Saint André - CHU de Bordeaux
Bordeaux, France
-
Hôpitaux Civils de Colmar - Hôpital Pasteur
Colmar, France
-
I.C.O. Gauducheau
Saint-Herblain, France
-
I.C.O. Paul Papin
Angers, France
-
ICO Badalona - Hospital Germans Trias i Pujol
Badalona, Spain
-
Institut Claudius Regaud - IUCT - Oncopole
Toulouse, France
-
Institut Curie
Paris, France
-
Institut Gustave Roussy
Villejuif, France
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.